TMB-365/TMB-380 (TMB-365 and TMB-380 combination)
Exhibitor: TAIMED BIOLOGICS INC.
Booth No: M104
Characteristic
With broad efficacy over clades of prevalent HIV-1 variants and the long in vivo lifetimes or PK half-life, long acting, of TMB-365 and TMB-380, the dual antibody combination of TMB-365 with TMB-380, like their peers, also dual antibody combination 3BNC117 and 10-1074, are approached for HIV-1 therapy and/or prophylaxis purposes. The TMB-365 and TMB-380 combination is designated for the treatment of HIV-1 in virologically suppressed patients.
Other Products
Highest Rated Products